| Literature DB >> 26782276 |
Seyda Ors Kaya1, Tevfik Ilker Akcam2, Kenan Can Ceylan1, Ozgur Samancılar1, Ozgur Ozturk1, Ozan Usluer1.
Abstract
OBJECTIVE: Protein-rich nutrition is necessary for wound healing after surgery. In this study, the benefit of preoperative nutritional support was investigated for non-small cell lung cancer patients who underwent anatomic resection.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26782276 PMCID: PMC4717613 DOI: 10.1186/s13019-016-0407-1
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Patients’ demographic data
| Control group | Nutrition group | Total |
| ||
|---|---|---|---|---|---|
| Agea | 59.04 ± 7.61/year | 57.80 ± 9.70/year | 58.35 ± 8.8/year | 0.482 | |
| Sex | Male | 25 (92.6 %) | 29 (93.5 %) | 54 (93.1 %) | 1 |
| Female | 2 (7.4 %) | 2 (6.5 %) | 4(6.9 %) | ||
| FEV-1a | 74.5 ± 15.01 % | 71.55 ± 15.52 % | 72.84 ± 15.23 % | 0.594 | |
| BMI | Thoracotomy | 26.7 ± 4.20 | 24.0 ± 3.69 | 25.21 ± 4.11 | 0.051 |
| VATS | 26.6 ± 2.26 | 27.3 ± 4.19 | 26.92 ± 3.31 | 0.632 | |
| Total | 26.7 ± 3.49 | 25.2 ± 4.13 | 25.86 ± 3.88 | 0.138 | |
| Operation Type | Thoracotomy | 16 (59.3 %) | 20 (64.5 %) | 36 (62.06 %) | 0.788 |
| VATS | 11 (40.7 %) | 11 (35.5 %) | 22 (37.94 %) | ||
| Resection Type | LUL | 5 (18.52 %) | 9 (29.03 %) | 14 (24.14 %) | 0.788 |
| LLL | 4 (14.81 %) | 6 (19.35 %) | 10 (17.24 %) | ||
| RLL | 5 (18.52 %) | 6 (19.35 %) | 11 (18.97 %) | ||
| L-P | 2 (7.41 %) | 5 (16.13 %) | 7 (12.07 %) | ||
| RUL | 8 (29.63 %) | 3 (9.68 %) | 11 (18.97 %) | ||
| RSBL | 2 (7.41 %) | 2 (6.45 %) | 4 (6.89 %) | ||
| RIBL | 1 (3.7 %) | 1 (1.72 %) | |||
| Drainage Timeb | 6 (42–1)/day | 4 (15–2)/day | 4.9 ± 2.26/day | 0.019 | |
| Complication | PAL | 7 (58.33 %) | 4 (66.67 %) | 11 (18 %) | |
| Atelectasis | 3 (25 %) | 1 (16.67 %) | 4 (6.8 %) | ||
| Pneumonia | 1 (8.33 %) | 1 (16.67 %) | 2 (3.4 %) | ||
| Arhytmia | 1 (8.33 %) | 1 (1.7 %) | |||
| Total | 12 (44.4 %) | 6 (19.4 %) | 18 (31.04 %) | 0.049 | |
| AC | 17 (62.96 %) | 12 (38.71 %) | 27 (46.55 %) | 0.122 | |
| Histology | SCC | 9 (33.33 %) | 18 (58.06 %) | 27 (46.55 %) | |
| Carcinoid | 1 (3.7 %) | 1 (3.23 %) | 2 (6.9 %) | ||
| Stage | IA | 7 (25.93 %) | 11 (35.48 %) | 18 (31.04 %) | 0.608 |
| IB | 6 (22.22 %) | 3 (9.68 %) | 9 (15.52 %) | ||
| IIA | 8 (29.63 %) | 7 (22.58 %) | 15 (25.86 %) | ||
| IIB | 3 (11.11 %) | 6 (19.35 %) | 9 (15.52 %) | ||
| IIIA | 3 (11.11 %) | 4 (12.9 %) | 7 (12.06 %) | ||
| Concomitant Diseases | Hypertension | 4 (44.44 %) | 5 (38.46 %) | 9 (40.91 %) | |
| COPD | 3 (23.08 %) | 3 (13.64 %) | |||
| CAD | 2 (15.38 %) | 2 (9.09 %) | |||
| MNG | 2 (22.22 %) | 1 (7.69 %) | 3 (13.64 %) | ||
| CHF | 1 (7.69 %) | 1 (4.55 %) | |||
| Asthma | 1 (7.69 %) | 1 (4.55 %) | |||
| AS | 1 (11.11 %) | 1 (4.55 %) | |||
| Parkinson | 1 (11.11 %) | 1 (4.55 %) | |||
| PVD | 1 (11.11 %) | 1 (4.55 %) | |||
| Total | 9 (33.3 %) | 13 (41.9 %) | 22 (37.9 %) | 0.592 |
Pearson Chi-Square Test (Monte Carlo) - Mann Whitney U Test (Monte Carlo) - Independent T Test (Bootstrap)
aMean ± SD, bMedyan Range (Maximum- Minimum), n (%)
BMI: Body Mass Index; VATS: Video-assisted thoracoscopic surgery; LUL: Left Upper Lobectomy; LLL: Left Lower Lobectomy; RLL: Right Lower Lobectomy; L-P: Left Pneumonectomy; RUL: Right Upper Lobectomy; RSBL: Right Superior Bilobectomy; RIBL: Right İnferior Bilobectomy; PAL: Prolonged Air Leak; AC: Adenocarcinoma; SCC: Squamous Cell Carcinoma; CAD: Coronary Artery Disease; COPD: Chronic obstructive pulmonary disease; MNG: Multinodular goiter; CHF: Congestive heart failure; AS: Ankylosing spondylitis; PVD: Peripheral vessel disease
Fig. 1Nutrition group albumin level
Patients’ albumin levels
| Preoperative albumin level (mg/dl) | Postoperative 3.day albumin level (mg/dl) | Albumin change |
| |
|---|---|---|---|---|
| C.G. VATS | 4,30 ± 0,45 | 3,15 ± 0,41 | 1,15 ± 0,44 (26.74 %) | 0,005 |
| N.G. VATS | 4,25 ± 0,23 | 3,60 ± 0,35 | 0,65 ± 0,27 (15.29 %) | |
| C.G. Thoracotomy | 4,13 ± 0,42 | 3,09 ± 0,31 | 1,04 ± 0,31 (25.18 %) | <0,001 |
| N.G. Thoracotomy | 4,09 ± 0,28 | 3,51 ± 0,36 | 0,58 ± 0,33 (14.18 %) | |
| C.G. Total | 4,20 ± 0,43 | 3,12 ± 0,35 | 1,08 ± 0,37 (25.71 %) | <0.001 |
| N.G. Total | 4,15 ± 0,27 | 3,54 ± 0,35 | 0,60 ± 0,31 (14,69 %) |
General Linear Model Repeated Anova (Wilks’ Lambda)
Mean ± Standard deviation
C.G Control group, N.G Nutrition group, VATS Video-assisted thoracoscopic surgery
Fig. 2Patients’ postoperative complications graphic
Fig. 3Drainage days graphic